Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | -0.03% | 535.63 | 1.0% | $648.52m | |
| DHR | Danaher Corp. | 0.36% | 252.78 | 0.7% | $635.19m | |
| MDT | Medtronic Plc | 1.28% | 90.34 | 0.6% | $612.83m | |
| ABT | Abbott Laboratories | 1.91% | 109.01 | 0.8% | $601.34m | |
| ISRG | Intuitive Surgical, Inc. | 0.30% | 202.59 | 0.8% | $423.22m | |
| BSX | Boston Scientific Corp. | 0.77% | 37.79 | 1.0% | $333.72m | |
| ALGN | Align Technology, Inc. | 0.10% | 242.15 | 6.4% | $293.90m | |
| BDX | Becton, Dickinson & Co. | 1.93% | 249.25 | 1.0% | $275.67m | |
| EW | Edwards Lifesciences Corp. | 1.33% | 95.99 | 0.4% | $271.04m | |
| SYK | Stryker Corp. | 0.89% | 198.86 | 1.3% | $258.39m | |
| IDXX | IDEXX Laboratories, Inc. | 2.58% | 358.22 | 3.8% | $231.23m | |
| A | Agilent Technologies, Inc. | 0.63% | 117.80 | 1.7% | $206.87m | |
| BAX | Baxter International, Inc. | 0.82% | 65.79 | 1.8% | $203.09m | |
| DXCM | DexCom, Inc. | 1.00% | 75.45 | 1.9% | $174.20m | |
| SWAV | Shockwave Medical, Inc. | -0.60% | 194.37 | 0.0% | $168.16m |
Company Profile
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Or Yehuda, Israel.